GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

SB-751689

Company
GlaxoSmithKline
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT00388596

    A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.

    Not yet reported GlaxoSmithKline 36 participants 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00468689

    Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.

    Not yet reported GlaxoSmithKline 15 participants Est. completion 2007-08 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00471237

    A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

    Not yet reported GlaxoSmithKline 564 participants Est. completion 2008-12-26 49 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00499928

    A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women

    Not yet reported GlaxoSmithKline 6 participants Est. completion 2007-07 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00508534

    A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People

    Not yet reported GlaxoSmithKline 13 participants Est. completion 2007-08 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00532077

    A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

    Not yet reported GlaxoSmithKline 40 participants Est. completion 2008-01 5 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00540878

    A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women

    Not yet reported GlaxoSmithKline 25 participants 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00548496

    A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius

    Not yet reported GlaxoSmithKline 86 participants Est. completion 2008-11-26 37 sites Stand-alone
    Other conditions: Fracture Healing
    View official trial listing →
  • Completed NCT NCT00554255

    A Study of SB751689 in Japanese Postmenopausal Women

    Not yet reported GlaxoSmithKline 18 participants Est. completion 2006-12-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01466335

    An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers

    Not yet reported GlaxoSmithKline 39 participants Est. completion 2012-03-05 1 site
    Other conditions: Bone Marrow Transplantation
    View official trial listing →
  • Completed NCT NCT01802892

    Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2013-04-02 1 site
    Other conditions: Transplantation, Stem Cell
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.